logo-loader
LON:VRP

Verona Pharma

Receive alerts
Market:
LON
Market Cap:
£50.19 m
Price
£0.48
Change
-0.73%
52 weeks high
120.90
52 weeks low
42.00

In brief

Verona Pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, cystic fibrosis and asthma. The Company is listed on the Nasdaq Global Market in the United States under the VRNA ticker and on the London Stock Exchange in the United Kingdom under the VRP.L ticker. Read more here about Verona Pharma's science and innovative therapeutics.